University of Arkansas researchers recently won a $145,000 award from the Department of Defense to study whether metabolic changes in tissue could give clues to where tumors might form, the university reports.
Narasimhan Rajaram, assistant professor of biomedical engineering, will lead the study. Kyle Quinn, assistant professor of biomedical engineering, will serve as co-investigator. Both are BMES members.
The research focuses on lung cancer. Rajaram will investigate the "field effect," a phenomenon that suggests studying seemingly-normal tissue around a tumor might reveal underlying genetic changes that indicate whether another tumor could form, according to the article.
"We're trying to determine if there are changes in the adjacent normal tissue," Rajaram said. "Are they pathologically normal but metabolically abnormal?"
Researchers will be using multiphoton microscopy, an advanced imaging technique used on living tissue, to examine three types of tissue: Normal tissue, tumor-adjacent tissue that appears normal, and tissue from a tumor. The goal is to understand how tumor-adjacent normal tissue might be different from truly normal tissue.
Read more HERE.

Gordana Vunjak-Novakovic Opens BMES Annual Meeting
This is the fifth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

NIH Prize Competitions: Crowdsourcing Biomedical Innovation
This is the sixth and final article in a series highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024...

BMES 2024 Early Registration is NOW OPEN!
2024 Early Registration is NOW OPEN! Register now and lock in those savings with early-bird pricing for the 2024 BMES Annual Meeting! Thousands of...

1 min read
IMPROVED BRAIN CHIP FOR PRECISION MEDICINE DEVELOPED AT U OF HOUSTON
The Akay Lab biomedical research team at the University of Houston has improved on a microfluidic brain cancer chip previously developed in their...

NEW CLASSIFICATION SYSTEM DEVELOPED FOR REGENERATIVE CELL-BASED THERAPIES
Dr. Cato T. Laurencin, CEO of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UConn Health, has created a new...